Christopher Hooper Goss MD
Pleural Disease
Professor, Medicine and Pediatrics, University of Washington School of Medicine
Join to view full profile
PO Box# 1959Seattle, WA 98195
Phone+1 206-598-4615
Fax+1 206-598-7214
Dr. Goss is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Critical Care Medicine (Internal Medicine), 2001
University of California (San Francisco)Residency, Internal Medicine, 1992 - 1995
University of Colorado School of Medicine Anschutz Medical CampusClass of 1992
Certifications & Licensure
WA State Medical License 1997 - 2026
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis in the United States.Georgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, Christopher H Goss, Raksha Jain
Annals of the American Thoracic Society. 2026-10-01 - 1 citationsRepresentation of minoritized people with cystic fibrosis in the Cystic Fibrosis Therapeutics Development Network clinical trials.Tijana Milinic, Amalia S Magaret, Crystal E Brown, Oliver J McElvaney, Nicole Mayer-Hamblett
Annals of the American Thoracic Society. 2026-10-01 - 1 citationsApproach to prevention and management of chronic lung allograft dysfunction in North American lung transplant centers.Siddhartha G Kapnadak, Tijana Milinic, Eric D Morrell, William Brandon, Megan Mayer
The Journal of Heart and Lung Transplantation. 2026-09-01
Press Mentions
- The Association Between Heroin Inhalation and Early Onset EmphysemaJuly 17th, 2020
Using 1 Germ to Fight Another When Today’s Antibiotics FailFebruary 26th, 2019
New Approach Against Antibiotic-Resistant Bacteria in CF Patients Shows Promise in Phase 1 TrialOctober 9th, 2018
Grant Support
- Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator EraSEATTLE CHILDREN'S HOSPITAL2010–2030
- Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator EraSEATTLE CHILDREN'S HOSPITAL2010–2030
- Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator EraSEATTLE CHILDREN'S HOSPITAL2010–2030
- A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study).SEATTLE CHILDREN'S HOSPITAL2020–2027
- Early Intervention In Pulmonary Exacerbation In CFNational Heart, Lung, And Blood Institute2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: